OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.190
-0.020 (-1.65%)
At close: Mar 10, 2026, 4:00 PM EDT
1.190
0.00 (-0.02%)
After-hours: Mar 10, 2026, 7:31 PM EDT

OPKO Health Revenue

In the year 2025, OPKO Health had annual revenue of $606.90M, down -14.90%. OPKO Health had revenue of $148.50M in the quarter ending December 31, 2025, a decrease of -19.13%.

Revenue (ttm)
$606.93M
Revenue Growth
-14.89%
P/S Ratio
1.49
Revenue / Employee
$266,760
Employees
2,275
Market Cap
903.29M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025606.90M-106.24M-14.90%
Dec 31, 2024713.14M-150.35M-17.41%
Dec 31, 2023863.50M-140.70M-14.01%
Dec 31, 20221.00B-770.52M-43.42%
Dec 31, 20211.77B339.31M23.64%
Dec 31, 20201.44B533.48M59.15%
Dec 31, 2019901.94M-88.33M-8.92%
Dec 31, 2018990.27M24.26M2.51%
Dec 31, 2017966.01M-151.49M-13.56%
Dec 31, 20161.12B625.76M127.25%
Dec 31, 2015491.74M400.61M439.63%
Dec 31, 201491.13M-5.41M-5.60%
Dec 31, 201396.53M49.49M105.19%
Dec 31, 201247.04M19.07M68.14%
Dec 31, 201127.98M-515.00K-1.81%
Dec 31, 201028.49M24.08M544.95%
Dec 31, 20094.42M-5.02M-53.20%
Dec 31, 20089.44M8.59M1,014.52%
Dec 31, 2007847.00K--
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Neogen880.32M
Myriad Genetics824.50M
NeoGenomics727.33M
Veracyte517.15M
GeneDx Holdings427.54M
CareDx379.81M
Castle Biosciences344.23M
Fulgent Genetics322.67M
Revenue Rankings